小鵬P5正式上市 綜合補貼後售價15.79萬至22.39萬人幣
小鵬汽車(09868.HK)宣佈,搭載激光雷達的量產智能汽車小鵬P5正式上市。全國補貼後零售價15.79萬元人民幣(下同)至22.39萬元,並將於10月底開始啓動交付。
小鵬P5擁有雙激光雷達在內的32個感知傳感器及一套亞米級高精定位單元,能夠實現對環境視覺+雷達360度的雙重融合感知。在XPILOT3.5智能輔助駕駛系統的支持下,小鵬P5具備城市NGP功能,NGP適用範圍從高速/快速路擴展至城市道路。
小鵬汽車官方微博日前宣佈,新增16座高速超充站,覆蓋京滬高速、雲南高速、綿遂高速。截至8月底,高速超充站已累計上線27座。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.